Astrazeneca Pharma India standalone net profit declines 32.06% in the June 2026 quarter

Sales rise 29.73% to Rs 682.79 crore
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.